Runben Biotechnology Co., Ltd. (SHA:603193)
34.87
+1.85 (5.60%)
Apr 24, 2025, 2:45 PM CST
Runben Biotechnology Revenue
Runben Biotechnology had revenue of 293.49M CNY in the quarter ending September 30, 2024, with 20.10% growth. This brings the company's revenue in the last twelve months to 1.25B, up 24.89% year-over-year. In the year 2023, Runben Biotechnology had annual revenue of 1.03B with 20.66% growth.
Revenue (ttm)
1.25B
Revenue Growth
+24.89%
P/S Ratio
11.32
Revenue / Employee
1.36M
Employees
917
Market Cap
14.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.03B | 176.87M | 20.66% |
Dec 31, 2022 | 856.09M | 273.94M | 47.06% |
Dec 31, 2021 | 582.15M | 139.32M | 31.46% |
Dec 31, 2020 | 442.83M | 164.19M | 58.93% |
Dec 31, 2019 | 278.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Kweichow Moutai | 170.90B |
Wuliangye Yibin | 88.65B |
Shanxi Xinghuacun Fen Wine Factory | 36.54B |
Foshan Haitian Flavouring and Food Company | 26.90B |
Muyuan Foods | 137.95B |
Luzhou Laojiao Co.,Ltd | 32.59B |
Inner Mongolia Yili Industrial Group | 117.81B |
Yihai Kerry Arawana Holdings | 238.87B |